Becton, Dickinson and Company Consumables — Revenue, remaining performance obligation, amount decreased by 16.7% to $2.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $2.20B to $2.00B. Over 4 years (FY 2021 to FY 2025), Consumables — Revenue, remaining performance obligation, amount shows a downward trend with a -4.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests a growing backlog of committed sales and stronger future revenue visibility, while a decrease may indicate faster fulfillment rates or softening demand for future consumable deliveries.
This metric represents the total transaction price allocated to performance obligations that are unsatisfied or partiall...
Peers in the medical device and life sciences sector often report this as 'Backlog' or 'Deferred Revenue' related to long-term supply agreements, though specific disclosure levels vary by contract structure.
bdx_segment_consumables_revenue_remaining_performance_obligation_amount| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.80B | $2.50B | $2.40B | $2.40B | $2.10B | $1.90B | $1.90B | $2.20B | $2.10B | $2.00B | $2.20B | $2.10B | $2.10B | $2.10B | $2.00B | $2.20B | $2.30B | $2.30B | $2.40B | $2.00B |
| QoQ Change | — | -10.7% | -4.0% | +0.0% | -12.5% | -9.5% | +0.0% | +15.8% | -4.5% | -4.8% | +10.0% | -4.5% | +0.0% | +0.0% | -4.8% | +10.0% | +4.5% | +0.0% | +4.3% | -16.7% |
| YoY Change | — | — | — | — | -25.0% | -24.0% | -20.8% | -8.3% | +0.0% | +5.3% | +15.8% | -4.5% | +0.0% | +5.0% | -9.1% | +4.8% | +9.5% | +9.5% | +20.0% | -9.1% |